Shanghai Shuzhidao Medical Technology

Shanghai Shuzhidao Medical Technology Co., Ltd., founded in 2021 with Yang Situ as its legal representative and chairman, is a platform-based company specializing in surgical robotics. The firm is dedicated to developing universal medical robot platforms and creating a complementary ecosystem of intelligent consumables designed for robotic surgery. Shuzhidao's strategy focuses on transforming surgical procedures by progressively implementing fully automated operations.

The company's product development is centered around three primary medical fields: medical aesthetics, oncology, and vascular intervention. To support this, Shuzhidao has established foundational technology platforms including a hybrid mechanical arm system, a visible light navigation system, a controllable catheter system, and an energy system. This approach allows the company to develop a diverse pipeline of over ten products that integrate the robotic platform with specialized smart consumables. In a significant milestone, the company announced in April 2022 that it had completed a Series A financing round, raising several hundred million yuan. The round was jointly led by Lize Capital and Jifeng Capital, with follow-on investments from Huatong Capital and IDG Capital, to further fund platform development and clinical trials.

Keywords: surgical robotics, medical robot platform, intelligent medical consumables, automated surgery, medical aesthetics robotics, oncology robotics, vascular intervention robotics, minimally invasive surgery, medical device technology, Yang Situ, Lize Capital, Jifeng Capital, IDG Capital